Text Size
1 study found for:    NCT01654263

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Condition: Pneumococcal Infections
Intervention: Biological: Prevnar 13 (PVC13)
To Top

† Indicates status has not been verified in more than two years